At 12 mg: 28.7% average weight loss Significant improvement in WOMAC pain scores more than 1 in 8 patients became completely free of knee pain Dysesthesia (tingling, altered skin sensation) in 20.9% of patients at 12 mg vs
CLA supplementation for 12 weeks in overweight and grade I obese subjects produced lower obesity indices, with no evident adverse effects
Its positive effects on metabolism were further demonstrated in an animal model of obesity, in which treatment with an alcohol extract of clove reduced the negative impact of a high-fat diet on body weight as well as lipid, glucose, and insulin levels (Jung 2012)
Muralidharan S, Nikalje M, Subramaniam T, Koshy JA, Koshy AV, Bangera D
GLP-1 medications are generally considered long-term therapies, meaning six months or longer
& Zandberg, L